Who We Are
- Who We Are
  
  We are a collaborative fund dedicated to ending six neglected tropical diseases that affect more than 1.4 billion people.
  
  The Board
  
  The Staff
  
  Partners
  
  Anchor Investors
What We Do
- What We Do
  
  We efficiently put drug donations and private capital to work in support of country-led NTD programs that are innovative, integrated, cost-effective, and sustainable.
  
  Our Story
  
  Our Impact
  
  Impact Stories
  
  THE LEGACY OF Pharmaceutical Partnerships
  
  Learn how pharmaceutical partnerships are driving the fight against neglected tropical diseases.
  
  Learn more
Support Our Work
- Support Our Work
  
  We believe that investing should be a transformative experience that enhances the lives of partners and beneficiaries alike. Support our mission and join us.
  
  INVEST
  
  The END Fund is dedicated to fighting the six most prevalent neglected tropical diseases, which affect 1.495 billion people globally.
  
  Annual reports
  
  Explore our annual reports and learn about the END Fund’s impact.
  
  Watch
  
  How the END Fund will end neglected tropical diseases.
Our Focus
- We focus on the six most prevalent NTDs that have proven cost-effective interventions: river blindness, lymphatic filariasis, trachoma, intestinal worms, schistosomiasis, and visceral leishmaniasis.
  
  Intestinal Worms
  
  Intestinal worms (also known as soil-transmitted helminths) cause malnutrition, anemia, and poor physical and mental growth.
  
  River Blindness
  
  River blindness (also known as onchocerciasis) is an eye and skin infection caused by parasitic worms that leads to intense itching and vision loss.
  
  Schistosomiasis
  
  Schistosomiasis (also known as bilharzia or snail fever) is a chronic disease caused by parasitic worms that live in freshwater snails.
  
  Lymphatic Filariasis
  
  Lymphatic filariasis (also known as elephantiasis) is a mosquito-borne disease that causes disfigurement and longterm disability.
  
  Trachoma
  
  Trachoma is a bacterial infection of the eye that can cause irreversible blindness. It is the leading cause of blindness due to infection worldwide.
  
  Visceral Leishmaniasis
  
  Visceral leishmaniasis (also known as kala-azar) is a life-threatening disease caused by leishmania parasites, transmitted by female sandflies.
Our Funds
- OUR FUNDS
  
  The END Fund manages a portfolio of programmatic funds to advance our vision to ensure that people at risk of neglected tropical diseases have the opportunity to live healthy and prosperous lives.
  
  FLAGSHIP FUND
  
  To ensure the everyone has access to treatment to live healthy lives.
  
  DEWORMING INNOVATION FUND
  
  To accelerate sustained improvements to the overall health and wellbeing of communities by rewriting the disease elimination playbook for parasitic worm infections.
  
  REACHING THE LAST MILE FUND
  
  To fast track the effort to eliminate river blindness and lymphatic filariasis.
  
  ARISE Fund
  
  To strengthen national and community leadership by co-financing programs with governments and improving efficiency and cost-effectiveness.
  
  Our Approach

Search

Search The End Fund

Marathon

WE’RE AT CAPACITY! This November, Team END Fund is heading to the streets of New York for the 2026 TCS New York City Marathon.

Please note: All spots for our 2026 team have now been filled, and applications are closed. We are incredibly grateful for the overwhelming interest and the dedication of our runners who have committed to raising funds to see an end to NTDs in our lifetime. If you missed out this year but would like to be notified about future endurance events or stay involved with our mission, please contact Stacy Potthoff at [email protected].

Still want to support the mission? While our runner roster is full, the race to see the end of neglected tropical diseases (NTDs) continues! You can still make a massive impact by supporting our current runners or donating directly to the END Fund.

About the END Fund

Founded on the principle that no one should be left behind, the END Fund helps communities and governments see an end to some of the most prevalent neglected tropical diseases by bringing together partners and investors from around the world to support the delivery of life-changing treatments, sight-restoring surgeries, and training healthcare workers.

USA: 2 Park Avenue , 28th Floor , New York, NY, 10016 phone: +1 646-690-9775 

UK: 495 Green Lanes, Palmer Green London, N13 4BS

Kenya: P.O. Box 10752 – 00100, Nairobi.

[email protected]

The END Fund Inc. is a 501(c)(3), tax-exempt charitable organization registered in the United States (EIN 27-3941186). The END Fund is a company limited by guarantee registered in England and Wales (company number 6350698) and a UK registered charity (number 1122574). The END Fund Kenya is a a non-governmental organization registered in the Republic of Kenya as NGO-POFQMD.

Careers

–

State Non-Profit Disclosures

–

US Gift Acceptance Policy

–

UK Gift Acceptance Policy

–

Annual Reports and Financial Statements

–